Premium
LONG‐TERM FOLLOW‐UP OF‘CURED’PROLACTINOMA PATIENTS AFTER SUCCESSFUL ADENOMECTOMY
Author(s) -
CICCARELLI ENRICA,
GHIGO EZIO,
MIOLA CATALDO,
GANDINI GIOVANNI,
MULLER EUGENIO E.,
CAMANNI FRANCO
Publication year - 1990
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/j.1365-2265.1990.tb00901.x
Subject(s) - domperidone , hyperprolactinaemia , prolactinoma , medicine , endocrinology , prolactin , dopaminergic , metoclopramide , hormone , trh stimulation test , dopamine antagonist , thyrotropin releasing hormone , antagonist , dopamine , receptor , vomiting
SUMMARY The long‐term follow‐up (±Mg4 years) of clinical, hormonal and radiological aspects in 22‘cured’prolactinoma patients after adenomectomy was studied. Dynamic secretion of PRL and TSH was also evaluated, in order to identify the persistence of any underlying abnormality of hypothalamic pituitary control and to predict relapses. A relapse into hyperprolactinaemia was shown in 36% of patients 5‐90 months (mean 46) after surgery. This was accompanied by reappearance of clinical symptoms but not by the radiological demonstration of the adenoma in any patients. A significant PRL rise after domperidone, a dopaminergic antagonist drug, was shown in cured patients after surgery (mean±SEM peak, 2977±645 mU/1) but this was markedly lower than that observed in control subjects (5732±440 mU/1). In fact, normal PRL increments were shown in only 6/16 (37%) patients. TSH hyper‐responsiveness to domperidone normalized in only 46% of patients. Similar PRL responses to those obtained with domperidone were shown when a TRH test was given. A relapse into hyperprolactinaemia was observed in six of ten (60%) non‐responders to domperidone and in four of seven (57%) non‐responders to TRH, whereas six normal responders to domperidone and TRH had not relapsed at that time. Plasma PRL levels during pregnancy showed increments lower than those observed in normal pregnant women only in domperidone and TRH non‐responder patients. These results indicate that a relapse into hyperprolactinaemia and a blunted PRL rise during pregnancy were present only in patients with persistently reduced PRL response to dynamic tests.